Charles River Laboratories International, Inc.

NYSE:CRL

162 (USD) • At close September 8, 2025
Bedrijfsnaam Charles River Laboratories International, Inc.
Symbool CRL
Munteenheid USD
Prijs 162
Beurswaarde 7,972,700,400
Dividendpercentage 0%
52-weken bereik 91.86 - 230.02
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. James C. Foster J.D.
Website https://www.criver.com

An error occurred while fetching data.

Over Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The

Vergelijkbare Aandelen

Elanco Animal Health Incorporated logo

Elanco Animal Health Incorporated

ELAN

19.05 USD

Qiagen N.V. logo

Qiagen N.V.

QGEN

47.58 USD

Biohaven Pharmaceutical Holding Company Ltd. logo

Biohaven Pharmaceutical Holding Company Ltd.

BHVN

14.49 USD

Organon & Co. logo

Organon & Co.

OGN

10.47 USD

Universal Health Services, Inc. logo

Universal Health Services, Inc.

UHS

185.76 USD

Teleflex Incorporated logo

Teleflex Incorporated

TFX

130.18 USD

DaVita Inc. logo

DaVita Inc.

DVA

134.51 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)